Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Immune response to chemically modified proteome.

Bhat S, Mary S, Banarjee R, Giri AP, Kulkarni MJ.

Proteomics Clin Appl. 2014 Feb;8(1-2):19-34. doi: 10.1002/prca.201300068. Review.

PMID:
24375944
2.

The clinical significance of posttranslational modification of autoantigens.

Zavala-Cerna MG, Martínez-García EA, Torres-Bugarín O, Rubio-Jurado B, Riebeling C, Nava A.

Clin Rev Allergy Immunol. 2014 Aug;47(1):73-90. doi: 10.1007/s12016-014-8424-0. Review.

PMID:
24840362
3.

The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases.

Papini AM.

J Pept Sci. 2009 Oct;15(10):621-8. doi: 10.1002/psc.1166. Review.

PMID:
19714713
4.

Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases.

Ganesan V, Ascherman DP, Minden JS.

Biomol Concepts. 2016 May 1;7(2):133-43. doi: 10.1515/bmc-2016-0007. Review.

PMID:
27115324
5.

Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.

Opdenakker G, Proost P, Van Damme J.

Trends Mol Med. 2016 Sep;22(9):746-57. doi: 10.1016/j.molmed.2016.07.002. Epub 2016 Aug 2.

PMID:
27491925
6.

Post-translational protein modifications in antigen recognition and autoimmunity.

Doyle HA, Mamula MJ.

Trends Immunol. 2001 Aug;22(8):443-9. Review.

PMID:
11473834
7.

Citrullination of autoantigens implicates NETosis in the induction of autoimmunity.

Dwivedi N, Radic M.

Ann Rheum Dis. 2014 Mar;73(3):483-91. doi: 10.1136/annrheumdis-2013-203844. Epub 2013 Nov 29. Review.

PMID:
24291655
8.

Molecular mechanisms of autoimmunity.

Atassi MZ, Casali P.

Autoimmunity. 2008 Mar;41(2):123-32. doi: 10.1080/08916930801929021. Review.

PMID:
18324481
10.

Consequence of neo-antigenicity of the 'altered self'.

Eggleton P, Haigh R, Winyard PG.

Rheumatology (Oxford). 2008 May;47(5):567-71. doi: 10.1093/rheumatology/ken014. Epub 2008 Mar 3. Review.

PMID:
18316337
11.

Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases.

Ryan BJ, Nissim A, Winyard PG.

Redox Biol. 2014 May 28;2:715-24. doi: 10.1016/j.redox.2014.05.004. eCollection 2014. Review.

12.

Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.

Routsias JG, Vlachoyiannopoulos PG, Tzioufas AG.

Crit Rev Clin Lab Sci. 2006;43(3):203-48. Review.

PMID:
16574554
13.

Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.

Terzoglou AG, Routsias JG, Moutsopoulos HM, Tzioufas AG.

Clin Exp Immunol. 2006 Oct;146(1):60-5.

14.

Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases.

Ohyama K, Baba M, Tamai M, Aibara N, Ichinose K, Kishikawa N, Kawakami A, Kuroda N.

Clin Biochem. 2015 Feb;48(3):181-5. doi: 10.1016/j.clinbiochem.2014.11.008. Epub 2014 Nov 29.

PMID:
25438073
15.

Functional genome and proteome analyses of cutaneous autoimmune diseases.

Trcka J, Kunz M.

Curr Pharm Des. 2006;12(29):3787-98. Review.

PMID:
17073677
16.
17.

Post-translational modifications of self antigens: implications for autoimmunity.

Anderton SM.

Curr Opin Immunol. 2004 Dec;16(6):753-8. Review.

PMID:
15511669
18.
19.

Proteasomal processing of nuclear autoantigens in systemic autoimmunity.

Chen M, von Mikecz A.

Autoimmun Rev. 2005 Mar;4(3):117-22. Review.

PMID:
15823496
20.

Posttranslational protein modifications: new flavors in the menu of autoantigens.

Doyle HA, Mamula MJ.

Curr Opin Rheumatol. 2002 May;14(3):244-9. Review.

PMID:
11981321

Supplemental Content

Support Center